Source: Metastatic prostate cancer cases surged following the issuance of U.S. Preventive Services Task Force recommendations against routine screening for the disease, according to research published Monday.

It was back in 2008 that the influential panel of experts urged against regular prostate-specific antigen testing among men older than 75, which spread to all ages by 2012. USPSTF had expressed concerns about over diagnosis and unnecessary treatment, while others countered that this could increase the occurrence of later stage results, experts wrote in JAMA Network Open.